Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multiinstitutional retrospective analysis of 134 patients.

MLA

Kazuhiro Tanaka, et al. “Feasibility and Efficacy of Gemcitabine and Docetaxel Combination Chemotherapy for Bone and Soft Tissue Sarcomas: Multiinstitutional Retrospective Analysis of 134 Patients.” World Journal of Surgical Oncology, vol. 14, Dec. 2016, pp. 1–10. EBSCOhost, https://doi.org/10.1186/s12957-016-1059-2.

APA

Kazuhiro Tanaka, Susumu Joyama, Hirokazu Chuman, Hiroaki Hiraga, Hideo Morioka, Hideki Yoshikawa, Masami Hosaka, Mitsuru Takahashi, Tadahiko Kubo, Hiroshi Hatano, Mitsunori Kaya, Junya Toguchida, Yoshihiro Nishida, Akihito Nagano, Hiroshi Tsumura, & Yukihide Iwamoto. (2016). Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multiinstitutional retrospective analysis of 134 patients. World Journal of Surgical Oncology, 14, 1–10. https://doi.org/10.1186/s12957-016-1059-2

Chicago

Kazuhiro Tanaka, Susumu Joyama, Hirokazu Chuman, Hiroaki Hiraga, Hideo Morioka, Hideki Yoshikawa, Masami Hosaka, et al. 2016. “Feasibility and Efficacy of Gemcitabine and Docetaxel Combination Chemotherapy for Bone and Soft Tissue Sarcomas: Multiinstitutional Retrospective Analysis of 134 Patients.” World Journal of Surgical Oncology 14 (December): 1–10. doi:10.1186/s12957-016-1059-2.